ATR Antibody - FFPE Validated

Skip to product information
1 of 1

BiCell Scientific

SKU:51302-FFPE-50UL

Regular price €500,00 EUR
Regular price Sale price €500,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
Blocking Peptide
Quantity
View full details

Biological Background

Use this antibody to examine ATR when mapping complex behavior and signaling context. ATR is a regulator within kinase-driven cascades that influence transcriptional and metabolic responses. Many projects interpret this target alongside interacting partners, upstream cues, and downstream readouts.

Tracking ATR can clarify whether changes reflect regulation, redistribution, or altered complex assembly.

Use in the Laboratory

Perturbations such as inhibitors or ligand stimulation can drive rapid shifts in localization or complex formation. Considering complex membership and compartment shifts can clarify whether changes reflect signaling or redistribution. In oncology research models, expression shifts can accompany changes in adhesion, signaling, or differentiation state.

Depending on the model, researchers may ask whether signal shifts reflect altered abundance, compartment changes, or remodeling of associated complexes.

To keep datasets interpretable, labs often document:

  • interaction patterns within multi-protein complexes
  • time-resolved changes following stimulation or inhibition
  • condition-to-condition comparisons with matched controls

Version Notes

Because fixation can mask epitopes, fixed-section oriented formats aim to maintain recognition after standard deparaffinization and retrieval steps. If your study compares multiple conditions, keep acquisition and processing settings stable to avoid confounding.

When interpreting ATR, consider whether changes track with compartment identity, cell density, or perturbation timing; these factors can influence apparent signal without implying a direct causal link.

Use the fixed-section version to relate ATR behavior to upstream cues and downstream consequences.

Targets:
ATR
Research Area:
Cancer • Cell Cycle • Cell Signaling • DNA Damage / Repair
Application:
IHC-P
Reactivity:
Human • Mouse • Rat
Host:
Rat
Clonality:
Polyclonal
Isotype:
IgG
Immunogen:
Synthetic peptide (19-aa) derived from the N-terminal region of human ATR protein
Conjugation:
Unconjugated
Purification:
Affinity Chromatography
Concentration:
0.25 mg/ml
UniProt:
Q13535
Homology:
Synthetic peptide sequence is identical to mouse or rat sequence
Storage Buffer:
PBS, pH 7.2, 0.1% Sodium Azide
Storage Temperature:
-20°C